CircCHD2/miR-200b-3p/HLF Axis Promotes Liver Cirrhosis

Authors:

Abstract
Inactivation of hepatic stellate cells (HSCs) slow down the liver cirrhosis (LC) advancement. The role of circular RNAs (circRNAs) in LC is largely undiscovered. Here, we clarified the effect of circCHD2 on HSCs. LX-2 cells were stimulated with TGF-β to establish cell model. The circCHD2, miR-200b-3p and HLF levels were measured using qPCR. Cell counting kit-8 assay, EdU assay and colony formation assay were all conducted to evaluate cell proliferation. The levels of α-SMA and Col1A1 were examined by qPCR and western blot. The targets of circCHD2 and miR-200b-3p were verified using luciferase reporter assay. We found the circCHD2 was upregulated in the patients with LC and TGF-β-activated LX-2 cells. Interfering of circCHD2 inhibited the proliferation of TGF-β-treated cells, and decreased α-SMA and Col1A1 levels. CircCHD2 served as a miR-200b-3p sponge, which directly targeted downstream HLF. Downregulation of miR-200b-3p abrogated the suppression on cell proliferation, α-SMA and Col1A1 levels induced by knockdown of circCHD2. Enforced HLF reversed the effect induced by overexpression of miR-200b-3p. Taken together, silencing of circCHD2/miR-200b-3p/HLF axis contributed to alleviate the progression of LC. The findings suggested that circCHD2 may be potential to be a therapeutic target of LC.

This publication has 31 references indexed in Scilit: